325 related articles for article (PubMed ID: 35275365)
1. Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?
Selvakumar D; Reyes L; Chong JJH
Curr Cardiol Rep; 2022 May; 24(5):445-461. PubMed ID: 35275365
[TBL] [Abstract][Full Text] [Related]
2. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
Selvakumar D; Clayton ZE; Chong JJH
Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
[TBL] [Abstract][Full Text] [Related]
3. Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.
Kadota S; Shiba Y
Curr Cardiol Rep; 2019 Jun; 21(8):73. PubMed ID: 31228011
[TBL] [Abstract][Full Text] [Related]
4. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
Oikonomopoulos A; Kitani T; Wu JC
Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
[TBL] [Abstract][Full Text] [Related]
5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
6. Proteomic and Glyco(proteo)mic tools in the profiling of cardiac progenitors and pluripotent stem cell derived cardiomyocytes: Accelerating translation into therapy.
Sebastião MJ; Marcos-Silva L; Gomes-Alves P; Alves PM
Biotechnol Adv; 2021; 49():107755. PubMed ID: 33895330
[TBL] [Abstract][Full Text] [Related]
7. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
Talkhabi M; Aghdami N; Baharvand H
Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
Tan SH; Loo SJ; Gao Y; Tao ZH; Su LP; Wang CX; Zhang SL; Mu YH; Cui YH; Abdurrachim D; Wang WH; Lalic J; Lim KC; Bu J; Tan RS; Lee TH; Zhang J; Ye L
Theranostics; 2021; 11(16):7879-7895. PubMed ID: 34335970
[No Abstract] [Full Text] [Related]
10. Heart regeneration using pluripotent stem cells.
Kadota S; Tanaka Y; Shiba Y
J Cardiol; 2020 Nov; 76(5):459-463. PubMed ID: 32690435
[TBL] [Abstract][Full Text] [Related]
11. The Role of Large Animal Models in Cardiac Regeneration Research Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Cheng YY; Hu YF; Hsieh PC
Curr Cardiol Rep; 2023 May; 25(5):325-331. PubMed ID: 37074564
[TBL] [Abstract][Full Text] [Related]
12. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
Duelen R; Sampaolesi M
EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
[TBL] [Abstract][Full Text] [Related]
13. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.
Garbern JC; Escalante GO; Lee RT
Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Promoted by Mechanical Stretch.
Gu X; Zhou F; Mu J
Med Sci Monit; 2021 Aug; 27():e931063. PubMed ID: 34381009
[TBL] [Abstract][Full Text] [Related]
15. Computational modeling of aberrant electrical activity following remuscularization with intramyocardially injected pluripotent stem cell-derived cardiomyocytes.
Yu JK; Liang JA; Weinberg SH; Trayanova NA
J Mol Cell Cardiol; 2022 Jan; 162():97-109. PubMed ID: 34487753
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration.
Kobayashi H; Tohyama S; Kanazawa H; Ichimura H; Chino S; Tanaka Y; Suzuki Y; Zhao J; Shiba N; Kadota S; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
J Mol Cell Cardiol; 2023 Jan; 174():77-87. PubMed ID: 36403760
[TBL] [Abstract][Full Text] [Related]
17. Making Cardiomyocytes from Pluripotent Stem Cells.
Karagiannis P; Yoshida Y
Methods Mol Biol; 2021; 2320():3-7. PubMed ID: 34302642
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?
White MC; Pang L; Yang X
Food Chem Toxicol; 2016 Dec; 98(Pt A):17-24. PubMed ID: 27265266
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent Stem Cells for Cardiac Regeneration - Current Status, Challenges, and Future Perspectives.
Shiba Y
Circ J; 2020 Nov; 84(12):2129-2135. PubMed ID: 33087630
[TBL] [Abstract][Full Text] [Related]
20. Subtype-specific cardiomyocytes for precision medicine: Where are we now?
Zhao MT; Shao NY; Garg V
Stem Cells; 2020 Jul; 38(7):822-833. PubMed ID: 32232889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
